629
Views
17
CrossRef citations to date
0
Altmetric
Acute Leukemia

Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemia

, , , , , , & show all
Pages 53-58 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Justin H. Reid, Anthony J. Perissinotti, Lydia Benitez, Dale L. Bixby, Patrick Burke, Kristen Pettit & Bernard L. Marini. (2020) Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis. Leukemia & Lymphoma 61:4, pages 862-868.
Read now

Articles from other publishers (16)

Qiukui Hao, Farid Foroutan, Mi Ah Han, Tahira Devji, Fernando Kenji Nampo, Sudipto Mukherjee, Shabbir M. H. Alibhai, Ashley Rosko, Mikkael A. Sekeres, Gordon H. Guyatt & Romina Brignardello-Petersen. (2022) Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review. PLOS ONE 17:12, pages e0278578.
Crossref
Marijana Juga & Marijana Virijević. (2022) Prognostic risk factors for early death in patients with acute myeloid leukemia. Srpski medicinski casopis Lekarske komore 3:1, pages 16-25.
Crossref
Mohamed L. Sorror, Barry E. StorerAmir T. Fathi, Andrew BrunnerAaron T. Gerds, Mikkael A. SekeresSudipto MukherjeeBruno C. MedeirosEunice S. WangPankit Vachhani, Paul J. ShamiEsteban PeñaMahmoud ElsawyKehinde Adekola, Selina LugerMaria R. BaerDavid Rizzieri, Tanya M. WildesJamie KoprivnikarJulie SmithMitchell GarrisonKiarash KojouriWendy Leisenring, Lynn OnstadJennifer E. Nyland, Pamela S. Becker, Jeannine S. McCune, Stephanie J. Lee, Brenda M. Sandmaier, Frederick R. AppelbaumElihu H. Estey. (2021) Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia. Blood 138:5, pages 387-400.
Crossref
Eshrak Al-Shaibani, Sunu Cyriac, Shiyi Chen, Jeffrey H. Lipton, Dennis D. Kim, Auro Viswabandya, Rajat Kumar, Wilson Lam, Arjun Law, Zeyad Al-Shaibani, Armin Gerbitz, Ivan Pasic, Jonas Mattsson & Fotios V. Michelis. (2021) Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia. Clinical Lymphoma Myeloma and Leukemia 21:6, pages e559-e568.
Crossref
Mikkael A. SekeresGordon GuyattGregory AbelShabbir AlibhaiJessica K. AltmanRena BucksteinHannah ChoePinkal DesaiHarry Erba, Christopher S. Hourigan, Thomas W. LeBlanc, Mark Litzow, Janet MacEachernLaura C. MichaelisSudipto MukherjeeKristen O’DwyerAshley RoskoRichard StoneArnav Agarwal, L. E. Colunga-Lozano, Yaping ChangQiuKui Hao & Romina Brignardello-Petersen. (2020) American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults. Blood Advances 4:15, pages 3528-3549.
Crossref
Rory M. Shallis, Prajwal C. Boddu, Jan Philipp Bewersdorf & Amer M. Zeidan. (2020) The golden age for patients in their golden years: The progressive upheaval of age and the treatment of newly-diagnosed acute myeloid leukemia. Blood Reviews 40, pages 100639.
Crossref
Rebecca L. Olin. (2019) Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care. Hematology 2019:1, pages 63-70.
Crossref
Rebecca L. Olin. (2019) Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care. Blood 134:23, pages 2013-2021.
Crossref
Thomas W. LeBlanc & Harry P. Erba. (2019) Shifting paradigms in the treatment of older adults with AML. Seminars in Hematology 56:2, pages 110-117.
Crossref
Heidi D. Klepin. (2016) Definition of Unfit for Standard Acute Myeloid Leukemia Therapy. Current Hematologic Malignancy Reports 11:6, pages 537-544.
Crossref
Kristen Pettit & Olatoyosi Odenike. (2015) Defining and Treating Older Adults with Acute Myeloid Leukemia Who Are Ineligible for Intensive Therapies. Frontiers in Oncology 5.
Crossref
Fotios V. Michelis, Hans A. Messner, Jieun Uhm, Naheed Alam, Anna Lambie, Laura McGillis, Matthew D. Seftel, Vikas Gupta, John Kuruvilla, Jeffrey H. Lipton & Dennis (Dong Hwan) Kim. (2015) Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI Score. Clinical Lymphoma Myeloma and Leukemia 15:5, pages e73-e81.
Crossref
Robert J. Orlowski, James K. Mangan & Selina M. Luger. (2015) Approach to patients with primary refractory acute myeloid leukemia. Current Opinion in Hematology 22:2, pages 97-107.
Crossref
Heidi D. Klepin. (2014) Geriatric perspective: how to assess fitness for chemotherapy in acute myeloid leukemia. Hematology 2014:1, pages 8-13.
Crossref
Heidi D. KlepinArati V. RaoTimothy S. Pardee. (2014) Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older Adults. Journal of Clinical Oncology 32:24, pages 2541-2552.
Crossref
Alexander E. Sherman, Gabriela Motyckova, K. Rebecca Fega, Daniel J. DeAngelo, Gregory A. Abel, David Steensma, Martha Wadleigh, Richard M. Stone & Jane A. Driver. (2013) Geriatric assessment in older patients with acute myeloid leukemia: A retrospective study of associated treatment and outcomes. Leukemia Research 37:9, pages 998-1003.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.